Form 4 · Filed Jun 2, 2026, 08:44 PM UTC
KNSA/Kiniksa Pharmaceuticals International, plc
Levy Richard S — director
AI Thesis
A thesis has not been generated for this filing yet — usually available within 60 seconds of EDGAR publication. Refresh shortly.
Research signal, not investment advice. Form 4 AI surfaces SEC filings and applies an analytical layer — it does not predict prices or recommend trades. Past performance does not guarantee future results. See methodology and public track record for how scores are computed.
Transactions
4 rows| Date | Code | Direction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| May 29, 2026 | M | other | 2,799 | — | — | 21,956 |
| May 29, 2026 | A | other | 12,158 | — | — | 12,158 |
| May 29, 2026 | A | other | 2,026 | — | — | 2,026 |
| May 29, 2026 | M | other | 2,799 | — | — | 0 |
Source: SEC EDGAR raw filing ↗ · Accession 0001454983-26-000004